Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcel Levi

Showing results (11-20 of 393) with videos related to

Pageof 40
Sort By:
Critical Care Medicine|March 11, 2003
Benefit of recombinant human activated protein C beyond 28-day mortality: there is more to life than deathMarcel Levi
Annals of Internal Medicine|September 21, 2011
ACP Journal Club. Dabigatran led to less major bleeding than warfarin in younger but not older patients with atrial fibrillationMarcel Levi
Seminars in Thrombosis and Hemostasis|April 19, 2012
Prohemostatic Interventions: what's New? PrefaceMarcel Levi
European Journal of Internal Medicine|August 9, 2005
New antithrombotics in the treatment of thromboembolic diseaseMarcel Levi
Critical Care (London, England)|December 17, 2005
Antithrombin in sepsis revisitedMarcel Levi
Hemasphere|June 7, 2021
Pathophysiology of Coagulopathy in Hematological Malignancies and in COVID-19Marcel Levi
Critical Care Medicine|May 2, 2008
Does sugar cause clotting? Intensive insulin treatment and activation of coagulationMarcel Levi
European Journal of Internal Medicine|January 10, 2017
Generalism in modern subspecializing medicineMarcel Levi
Thrombosis and Haemostasis|March 11, 2008
A long-awaited small step forward in the management of the post-thrombotic syndromeMarcel Levi
Blood|February 15, 2014
The dual face of heparin in severe infectionMarcel Levi
Pageof 40

Showing results (11-20 of 393) with videos related to

Sort By:
Pageof 40
Critical Care Medicine|March 11, 2003
Benefit of recombinant human activated protein C beyond 28-day mortality: there is more to life than deathMarcel Levi
Annals of Internal Medicine|September 21, 2011
ACP Journal Club. Dabigatran led to less major bleeding than warfarin in younger but not older patients with atrial fibrillationMarcel Levi
Seminars in Thrombosis and Hemostasis|April 19, 2012
Prohemostatic Interventions: what's New? PrefaceMarcel Levi
European Journal of Internal Medicine|August 9, 2005
New antithrombotics in the treatment of thromboembolic diseaseMarcel Levi
Critical Care (London, England)|December 17, 2005
Antithrombin in sepsis revisitedMarcel Levi
Hemasphere|June 7, 2021
Pathophysiology of Coagulopathy in Hematological Malignancies and in COVID-19Marcel Levi
Critical Care Medicine|May 2, 2008
Does sugar cause clotting? Intensive insulin treatment and activation of coagulationMarcel Levi
European Journal of Internal Medicine|January 10, 2017
Generalism in modern subspecializing medicineMarcel Levi
Thrombosis and Haemostasis|March 11, 2008
A long-awaited small step forward in the management of the post-thrombotic syndromeMarcel Levi
Blood|February 15, 2014
The dual face of heparin in severe infectionMarcel Levi
Pageof 40